Laurence A. Turka M.D.
Net Worth
Last updated:
What is Laurence A. Turka M.D. net worth?
The estimated net worth of Mr. Laurence A. Turka M.D. is at least $2,133,640 as of 31 Jan 2023. He owns shares worth $1,653 as insider, has earned $17,167 from insider trading and has received compensation worth at least $2,114,820 in Rubius Therapeutics, Inc..
What is the salary of Laurence A. Turka M.D.?
Mr. Laurence A. Turka M.D. salary is $704,940 per year as Chief Scientific Officer and Head of Research & Translational Medicine in Rubius Therapeutics, Inc..
How old is Laurence A. Turka M.D.?
Mr. Laurence A. Turka M.D. is 67 years old, born in 1958.
What stocks does Laurence A. Turka M.D. currently own?
As insider, Mr. Laurence A. Turka M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. (RUBY) | Chief Scientific Officer and Head of Research & Translational Medicine | 18,391 | $0.09 | $1,653 |
What does Rubius Therapeutics, Inc. do?
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
Laurence A. Turka M.D. insider trading
Rubius Therapeutics, Inc.
Mr. Laurence A. Turka M.D. has made 2 insider trades between 2022-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 8,625 units of RUBY stock on 31 Jan 2023. As of 31 Jan 2023 he still owns at least 18,391 units of RUBY stock.
Rubius Therapeutics key executives
Rubius Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Pablo J. Cagnoni Ph.D., M.D. (62) Chief Executive Officer, Pres & Director
- Mr. David R. Epstein B.Sc., M.B.A. (63) Executive Chairman
- Mr. Laurence A. Turka M.D. (67) Chief Scientific Officer and Head of Research & Translational Medicine